Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients
Feng Chen
State Key Laboratory of Infectious Disease Diagnosis and Treatment, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Search for more papers by this authorHaihong Zhu
State Key Laboratory of Infectious Disease Diagnosis and Treatment, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Search for more papers by this authorGuoping Peng
State Key Laboratory of Infectious Disease Diagnosis and Treatment, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Search for more papers by this authorZhi Chen
State Key Laboratory of Infectious Disease Diagnosis and Treatment, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Search for more papers by this authorFeng Chen
State Key Laboratory of Infectious Disease Diagnosis and Treatment, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Search for more papers by this authorHaihong Zhu
State Key Laboratory of Infectious Disease Diagnosis and Treatment, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Search for more papers by this authorGuoping Peng
State Key Laboratory of Infectious Disease Diagnosis and Treatment, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Search for more papers by this authorZhi Chen
State Key Laboratory of Infectious Disease Diagnosis and Treatment, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Search for more papers by this authorAbstract
Background and Aims: Th17 cells have been shown to mediate host defensive mechanisms in various infections, but their role in HBV infection in humans has not been well characterized. In this study, we analyzed the frequency and cytokines secretion of circulating Th17 cells in HBV infected patients with different statuses, and also evaluated the potential association of Th17 frequency with the levels of liver injury.
Methods: The study population consisted of 133 subjects, including 40 mild chronic hepatitis B (CHB) patients, 37 severe CHB patients, 20 acute hepatitis B (AHB) patients and 36 healthy controls. The frequency of circulating Th17 cells were carried out by intracellular cytokine staining analysis and serum IL-10 levels were measured by ELISA.
Results: Our data shown that AHB and severe CHB patients had a significant increase of Th17 cells frequency in peripheral blood compared with mild CHB patients and healthy control (both P < 0.05). The elevated prevalence of Th17 cells is positively associated with the increased serum ALT levels in severe CHB patients (r= 0.457, P= 0.004) but had no correlation with serum HBV DNA load. In addition, the serum IL-10 were negatively correlated with the frequency of Th17 cells in PBMC from patients with chronic HBV infection (r=−0.452, P < 0.01).
Conclusion: Th17 cells may contribute to the disease progression and pathogenesis of liver injury in HBV infected patients, and the induction of IL-10 may be one mechanism of constraining pro-inflammatory Th17 responses.
References
- 1 McMahon BJ. Epidemiology and natural history of hepatitis B. Semin. Liver Dis. 2005; 25 (Suppl 1): 3–8.
- 2 Rehermann B. Intrahepatic T cells in hepatitis B: viral control versus liver cell injury. J. Exp. Med. 2000; 191: 1263–8.
- 3 Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989; 7: 145–73.
- 4 Langrish CL, Chen Y, Blumenschein WM et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005; 201: 233–40.
- 5 Ivanov II, McKenzie BS, Zhou L et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126: 1121–33.
- 6 Dambacher J, Beigel F, Zitzmann K et al. The role of interleukin-22 in hepatitis C virus infection. Cytokine 2008; 41: 209–16.
- 7 Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28: 454–67.
- 8 Eberl G, Marmon S, Sunshine MJ et al. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 2004; 5: 64–73.
- 9 Chen Y, Langrish CL, McKenzie B et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 2006; 116: 1317–26.
- 10 Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 2007; 13: 139–45.
- 11 Afzali B, Lombardi G, Lechler RI et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 2007; 148: 32–46.
- 12 Khader SA, Bell GK, Pearl JE et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 2007; 8: 369–77.
- 13 Yasumi Y, Takikawa Y, Endo R et al. Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatol. Res. 2007; 37: 248–54.
- 14 Zenewicz LA, Yancopoulos GD, Valenzuela DM et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007; 27: 647–59.
- 15 Rowan AG, Fletcher JM, Ryan EJ et al. Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta. J. Immunol. 2008; 181: 4485–94.
- 16 Webster GJ, Reignat S, Brown D et al. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J. Virol. 2004; 78: 5707–19.
- 17 Xu D, Fu J, Jin L et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 2006; 177: 739–47.
- 18 Xu XW, Lu MH, Tan DM. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin. Microbiol. Infect. 2005; 11: 52–6.
- 19 Han M, Yan W, Guo W et al. Hepatitis B virus-induced hFGL2 transcription is dependent on c-Ets-2 and MAPK signal pathway. J. Biol. Chem. 2008; 283: 32715–29.
- 20 Ke WM, Ye YN, Huang S. Discriminant function for prognostic indexes and probability of death in chronic severe hepatitis B. J. Gastroenterol. 2003; 38: 861–4.
- 21 Tang C, Chen Z, Peng G et al. Analysis of differential gene expression between chronic hepatitis B patients and asymptomatic hepatitis B carriers. J. Gastroenterol. Hepatol. 2007; 22: 68–73.
- 22 Pitcher C, Honing S, Fingerhut A et al. Cluster of differentiation antigen 4 (CD4) endocytosis and adaptor complex binding require activation of the CD4 endocytosis signal by serine phosphorylation. Mol. Biol. Cell. 1999; 10: 677–91.
- 23 Aujla SJ, Chan YR, Zheng M et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 2008; 14: 275–81.
- 24 Hyodo N, Tajimi M, Ugajin T et al. Frequencies of interferon-gamma and interleukin-10 secreting cells in peripheral blood mononuclear cells and liver infiltrating lymphocytes in chronic hepatitis B virus infection. Hepatol. Res. 2003; 27: 109–16.
- 25 Tulek N, Saglam SK, Saglam M et al. Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection. Hepatogastroenterology 2000; 47: 828–31.
- 26 Boissier MC, Assier E, Falgarone G et al. Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine 2008; 75: 373–5.
- 27 Oboki K, Ohno T, Saito H et al. Th17 and allergy. Allergol. Int. 2008; 57: 121–34.
- 28 Shin HC, Benbernou N, Esnault S et al. Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway. Cytokine 1999; 11: 257–66.
- 29 Michel ML, Keller AC, Paget C et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J. Exp. Med. 2007; 204: 995–1001.
- 30 Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21: 467–76.
- 31 Moseley TA, Haudenschild DR, Rose L et al. Interleukin-17 family and IL-17 receptors. Cytokine. Growth. Factor. Rev. 2003; 14: 155–74.
- 32 Tanaka J, Watanabe N, Kido M et al. Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions. Clin. Exp. Allergy 2009; 39: 89–100.
- 33 Brenchley JM, Paiardini M, Knox KS et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008; 112: 2826–35.
- 34 Ndhlovu LC, Chapman JM, Jha AR et al. Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection. AIDS 2008; 22: 990–2.
- 35 Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J. Clin. Virol. 2005; 34 (Suppl. 1): S1–3.
- 36 Wei L, Laurence A, Elias KM et al. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J. Biol. Chem. 2007; 282: 34605–10.
- 37 Liang SC, Tan XY, Luxenberg DP et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 2006; 203: 2271–9.
- 38 Eberl G, Littman DR. Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells. Science 2004; 305: 248–51.
- 39 Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989; 170: 2081–95.
- 40 Gu Y, Yang J, Ouyang X et al. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur. J. Immunol. 2008; 38: 1807–13.
Citing Literature
